Today, companies including Religare Enterprises, Gland Pharma, Fortis Malar Hospitals, Aditya Birla Capital, Alembic Pharma, ...

Sundaram Finance reported a 16% YoY rise in Q3 net profit to Rs 349 crore and a 22% increase in revenue to Rs1,648 crore.

Generic injectables maker Gland Pharma on February 3 reported a 7% rise in third-quarter profit, as lower expenses helped ...

In the corresponding quarter of the previous fiscal, KEC International posted a net profit of ₹96.9 crore, the company said ...

The company's revenue from operations increased 3 percent to Rs 11,550 crore as against Rs 11,233 crore in the corresponding ...

Tata Chemicals Ltd on Monday (February 3) reported a net loss of ₹21 crore for the third quarter against a net profit of ₹194 ...